1498 related articles for article (PubMed ID: 14707555)
1. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
2. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
[TBL] [Abstract][Full Text] [Related]
3. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.
López A; Lorente JA; Steingrub J; Bakker J; McLuckie A; Willatts S; Brockway M; Anzueto A; Holzapfel L; Breen D; Silverman MS; Takala J; Donaldson J; Arneson C; Grove G; Grossman S; Grover R
Crit Care Med; 2004 Jan; 32(1):21-30. PubMed ID: 14707556
[TBL] [Abstract][Full Text] [Related]
4. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
Grover R; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
Crit Care Med; 1999 May; 27(5):913-22. PubMed ID: 10362413
[TBL] [Abstract][Full Text] [Related]
5. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
Hussein Z; Beerahee M; Grover R; Jordan B; Jeffs R; Donaldson J; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
Clin Pharmacol Ther; 1999 Jan; 65(1):1-9. PubMed ID: 9951425
[TBL] [Abstract][Full Text] [Related]
7. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW
Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
[TBL] [Abstract][Full Text] [Related]
9. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.
Boerma EC; Koopmans M; Konijn A; Kaiferova K; Bakker AJ; van Roon EN; Buter H; Bruins N; Egbers PH; Gerritsen RT; Koetsier PM; Kingma WP; Kuiper MA; Ince C
Crit Care Med; 2010 Jan; 38(1):93-100. PubMed ID: 19730258
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, randomized, placebo-controlled study of the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene in distributive shock.
Kinasewitz GT; Privalle CT; Imm A; Steingrub JS; Malcynski JT; Balk RA; DeAngelo J
Crit Care Med; 2008 Jul; 36(7):1999-2007. PubMed ID: 18552688
[TBL] [Abstract][Full Text] [Related]
11. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep.
Westphal M; Stubbe H; Sielenkämper AW; Ball C; Van Aken H; Borgulya R; Bone HG
Crit Care Med; 2003 May; 31(5):1502-8. PubMed ID: 12771625
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model.
Holger JS; Dries DJ; Barringer KW; Peake BJ; Flottemesch TJ; Marini JJ
Acad Emerg Med; 2010 Apr; 17(4):429-35. PubMed ID: 20370783
[TBL] [Abstract][Full Text] [Related]
13. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
14. High-dose vasopressin is not superior to norepinephrine in septic shock.
Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?
De Backer D; Creteur J; Silva E; Vincent JL
Crit Care Med; 2003 Jun; 31(6):1659-67. PubMed ID: 12794401
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock.
Warrillow S; Egi M; Bellomo R
Crit Care Med; 2006 Apr; 34(4):980-5. PubMed ID: 16484892
[TBL] [Abstract][Full Text] [Related]
17. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
Morelli A; Lange M; Ertmer C; Broeking K; Van Aken H; Orecchioni A; Rocco M; Bachetoni A; Traber DL; Landoni G; Pietropaoli P; Westphal M
Shock; 2007 Nov; 28(5):530-5. PubMed ID: 17589379
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
[TBL] [Abstract][Full Text] [Related]
19. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Jacobs S; Price Evans DA; Tariq M; Al Omar NF
Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.
Rice TW; Wheeler AP; Bernard GR; Vincent JL; Angus DC; Aikawa N; Demeyer I; Sainati S; Amlot N; Cao C; Ii M; Matsuda H; Mouri K; Cohen J
Crit Care Med; 2010 Aug; 38(8):1685-94. PubMed ID: 20562702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
